Successful treatment of malar dermal melasma with a fractional ablative CO₂ laser in a patient with type V skin.
Melasma is a common disorder of hypermelanosis, and although numerous treatment modalities have been employed, many cases are refractory to treatment or the improvement after therapy is temporary. The clinical files, treatment parameters, and photographs of a 59-year-old female with black skin with refractory malar dermal melasma treated using a fractionally ablative CO₂ laser (Affirm 10,600 nm) for seven sessions were carefully reviewed. After treatment, clinical improvement was achieved. The fractional ablative CO₂ laser is a potentially safe and effective modality for the treatment of dermal melasma in Fitzpatrick type V skin.